Richard G Stock, MD
img_Richard G Stock
PROFESSOR | Radiation Oncology
Are you a patient?
Specialties
Radiation Oncology
Dr. Stock's specific focus is prostate cancer and prostate brachytherapy.  He established a comprehensive prostate cancer database with a corresponding IRB approved protocol to track treatment outcomes following prostate cancer therapies.  This has enabled him to obtain important medical information on the growing field of low dose rate brachytherapy and prostate cancer. Dr. Stock's efforts over the past 16 years, which includes 145 peer reviewed and invited papers, and book chapters, have contributed much to our understanding of prostate brachytherapy.  He has helped set standards for dosing issues and implant quality. In addition, he has collaborated with other brachytherapy centers to publish multi-institutional series which have further enhanced our understanding of this treatment modality.  Working in collaboration with other researchers, Dr. Stock has studied the relationship between genetic mutations and radiation side effects in patients undergoing radiation for prostate cancer.  He is a co-investigator on a Department of Defense, American Cancer Society, and NIH RO1 grants to study this new and exciting area of research. In a recent publication in the International Journal of Radiation Oncology Biology Physics, Dr. Stock ranked among the top 4% of academic radiation oncologists in terms of the h-factor, a surrogate score for research productivity.

MD, Icahn School of Medicine at Mount Sinai

Internship, Internal Medicine, Mount Sinai Beth Israel

Residency, Internal Medicine, Beth Israel Medical Center-Petrie Division

Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center

Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center

Certifications

Radiation Oncology

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Stock has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.